Novo Nordisk

Healthcare

AI Wants to be the Future of Drug Discovery

Photo by News Øresund – Kristoffer Dahl via CC BY 3.0

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

2 min read

Photo by Chemist4U via CC BY-SA 2.0

Healthcare

2025 is the Year of the Weight Loss Pill

Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.

2 min read
Photo by Coolcaesar via CC BY-SA 4.0

Healthcare

Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.

2 min read
Photo via Novo Nordisk

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Healthcare

Weight-Loss Drugs Might Not Tank Medicare After All

Photo by Andres Ayrton via Pexels

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

2 min read

Healthcare

Hims & Hers Stock Jumps On New Discount Weight-Loss Drug Offering

Photo by Fin vs Fin via CC BY 2.0

A loophole lets the company create a back-door offering of a generic drug before the patents of Novo Nordisk and Eli Lilly expire.

2 min read

Healthcare

Novo Nordisk May Have Found an Even Better Anti-Obesity Drug

Photo via Novo Nordisk

Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.

2 min read